Literature DB >> 31705425

Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome.

William Todd Cade1,2, Richard Laforest3, Kathryn L Bohnert4, Dominic N Reeds5, Adam J Bittel4, Lisa de Las Fuentes5, Adil Bashir3,6, Pamela K Woodard3, Christina A Pacak7, Barry J Byrne7, Robert J Gropler3, Linda R Peterson5,3.   

Abstract

BACKGROUND: Barth syndrome (BTHS) is a rare X-linked condition resulting in cardiomyopathy, however; the effects of BTHS on myocardial substrate metabolism and its relationships with cardiac high-energy phosphate metabolism and left ventricular (LV) function are unknown. We sought to characterize myocardial glucose, fatty acid (FA), and leucine metabolism in BTHS and unaffected controls and examine their relationships with cardiac high-energy phosphate metabolism and LV function. METHODS/
RESULTS: Young adults with BTHS (n = 14) and unaffected controls (n = 11, Control, total n = 25) underwent bolus injections of 15O-water and 1-11C-glucose, palmitate, and leucine and concurrent positron emission tomography imaging. LV function and cardiac high-energy phosphate metabolism were examined via echocardiography and 31P magnetic resonance spectroscopy, respectively. Myocardial glucose extraction fraction (21 ± 14% vs 10 ± 8%, P = .03) and glucose utilization (828.0 ± 470.0 vs 393.2 ± 361.0 μmol·g-1·min-1, P = .02) were significantly higher in BTHS vs Control. Myocardial FA extraction fraction (31 ± 7% vs 41 ± 6%, P < .002) and uptake (0.25 ± 0.04 vs 0.29 ± 0.03 mL·g-1·min-1, P < .002) were significantly lower in BTHS vs Control. Altered myocardial metabolism was associated with lower cardiac function in BTHS.
CONCLUSIONS: Myocardial substrate metabolism is altered and may contribute to LV dysfunction in BTHS. Clinical Trials #: NCT01625663.
© 2019. American Society of Nuclear Cardiology.

Entities:  

Keywords:  Metabolic; PET; cardiomyopathy; metabolism imaging agents

Mesh:

Substances:

Year:  2019        PMID: 31705425      PMCID: PMC7205570          DOI: 10.1007/s12350-019-01933-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  41 in total

1.  Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane.

Authors:  Mei Zhang; Eugenia Mileykovskaya; William Dowhan
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

2.  Impaired cardiac reserve and severely diminished skeletal muscle O₂ utilization mediate exercise intolerance in Barth syndrome.

Authors:  Carolyn T Spencer; Barry J Byrne; Randall M Bryant; Renee Margossian; Melissa Maisenbacher; Petar Breitenger; Paul B Benni; Sharon Redfearn; Edward Marcus; W Todd Cade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-26       Impact factor: 4.733

3.  Cardiac and clinical phenotype in Barth syndrome.

Authors:  Carolyn T Spencer; Randall M Bryant; Jane Day; Iris L Gonzalez; Steven D Colan; W Reid Thompson; Julie Berthy; Sharon P Redfearn; Barry J Byrne
Journal:  Pediatrics       Date:  2006-07-17       Impact factor: 7.124

4.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

5.  Clinical Characteristics and Outcomes of Cardiomyopathy in Barth Syndrome: The UK Experience.

Authors:  Sok-Leng Kang; Jonathan Forsey; Declan Dudley; Colin G Steward; Beverly Tsai-Goodman
Journal:  Pediatr Cardiol       Date:  2015-09-04       Impact factor: 1.655

6.  Impaired cardiac and skeletal muscle bioenergetics in children, adolescents, and young adults with Barth syndrome.

Authors:  Adil Bashir; Kathryn L Bohnert; Dominic N Reeds; Linda R Peterson; Adam J Bittel; Lisa de Las Fuentes; Christina A Pacak; Barry J Byrne; W Todd Cade
Journal:  Physiol Rep       Date:  2017-02

Review 7.  Barth syndrome.

Authors:  Sarah L N Clarke; Ann Bowron; Iris L Gonzalez; Sarah J Groves; Ruth Newbury-Ecob; Nicol Clayton; Robin P Martin; Beverly Tsai-Goodman; Vanessa Garratt; Michael Ashworth; Valerie M Bowen; Katherine R McCurdy; Michaela K Damin; Carolyn T Spencer; Matthew J Toth; Richard I Kelley; Colin G Steward
Journal:  Orphanet J Rare Dis       Date:  2013-02-12       Impact factor: 4.123

8.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.

Authors:  Gang Wang; Megan L McCain; Luhan Yang; Aibin He; Francesco Silvio Pasqualini; Ashutosh Agarwal; Hongyan Yuan; Dawei Jiang; Donghui Zhang; Lior Zangi; Judith Geva; Amy E Roberts; Qing Ma; Jian Ding; Jinghai Chen; Da-Zhi Wang; Kai Li; Jiwu Wang; Ronald J A Wanders; Wim Kulik; Frédéric M Vaz; Michael A Laflamme; Charles E Murry; Kenneth R Chien; Richard I Kelley; George M Church; Kevin Kit Parker; William T Pu
Journal:  Nat Med       Date:  2014-05-11       Impact factor: 53.440

9.  Loss of protein association causes cardiolipin degradation in Barth syndrome.

Authors:  Yang Xu; Colin K L Phoon; Bob Berno; Kenneth D'Souza; Esthelle Hoedt; Guoan Zhang; Thomas A Neubert; Richard M Epand; Mindong Ren; Michael Schlame
Journal:  Nat Chem Biol       Date:  2016-06-27       Impact factor: 15.040

10.  A novel X-linked gene, G4.5. is responsible for Barth syndrome.

Authors:  S Bione; P D'Adamo; E Maestrini; A K Gedeon; P A Bolhuis; D Toniolo
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

View more
  8 in total

1.  Sex Differences Across the Lifespan: A Focus on Cardiometabolism.

Authors:  T Rajendra Kumar; Jane E B Reusch; Wendy M Kohrt; Judith G Regensteiner
Journal:  J Womens Health (Larchmt)       Date:  2020-05-17       Impact factor: 2.681

Review 2.  Novel Tracers and Radionuclides in PET Imaging.

Authors:  Christian Mason; Grayson R Gimblet; Suzanne E Lapi; Jason S Lewis
Journal:  Radiol Clin North Am       Date:  2021-09       Impact factor: 1.947

3.  Arginine kinetics are altered in a pilot sample of adolescents and young adults with Barth syndrome.

Authors:  W Todd Cade; Kathryn L Bohnert; Adam J Bittel; Shaji J Chacko; Bruce W Patterson; Christina A Pacak; Barry J Byrne; Hilary J Vernon; Dominic N Reeds
Journal:  Mol Genet Metab Rep       Date:  2020-11-04

4.  Mitochondrial dysfunction in heart failure. Lessons from a hereditary mitochondrial disease.

Authors:  Richard C Brunken
Journal:  J Nucl Cardiol       Date:  2019-12-16       Impact factor: 5.952

Review 5.  Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies.

Authors:  Christina Wasmus; Jan Dudek
Journal:  Life (Basel)       Date:  2020-11-11

6.  Resistance exercise training with protein supplementation improves skeletal muscle strength and improves quality of life in late adolescents and young adults with Barth syndrome: A pilot study.

Authors:  Kathryn L Bohnert; Grace Ditzenberger; Adam J Bittel; Lisa de Las Fuentes; Manuela Corti; Christina A Pacak; Carolyn Taylor; Barry J Byrne; Dominic N Reeds; W Todd Cade
Journal:  JIMD Rep       Date:  2021-08-09

Review 7.  Myocardial disturbances of intermediary metabolism in Barth syndrome.

Authors:  Amanda A Greenwell; Seyed Amirhossein Tabatabaei Dakhili; John R Ussher
Journal:  Front Cardiovasc Med       Date:  2022-08-10

8.  Stimulating myocardial pyruvate dehydrogenase activity fails to alleviate cardiac abnormalities in a mouse model of human Barth syndrome.

Authors:  Amanda A Greenwell; Seyed Amirhossein Tabatabaei Dakhili; Keshav Gopal; Christina T Saed; Jordan S F Chan; Nick Kazungu Mugabo; Pavel Zhabyeyev; Farah Eaton; Jennifer Kruger; Gavin Y Oudit; John R Ussher
Journal:  Front Cardiovasc Med       Date:  2022-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.